These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 37409128)

  • 1. IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation.
    Lee J; Lee K; Bae H; Lee K; Lee S; Ma J; Jo K; Kim I; Jee B; Kang M; Im SJ
    Front Immunol; 2023; 14():1117092. PubMed ID: 37409128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection.
    Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.
    Klein S; Ghersi D; Manns MP; Prinz I; Cornberg M; Kraft ARM
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade.
    Jadhav RR; Im SJ; Hu B; Hashimoto M; Li P; Lin JX; Leonard WJ; Greenleaf WJ; Ahmed R; Goronzy JJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14113-14118. PubMed ID: 31227606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and anatomic location of PD-1
    Im SJ; Obeng RC; Nasti TH; McManus D; Kamphorst AO; Gunisetty S; Prokhnevska N; Carlisle JW; Yu K; Sica GL; Cardozo LE; Gonçalves ANA; Kissick HT; Nakaya HI; Ramalingam SS; Ahmed R
    Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221985120. PubMed ID: 37782797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.
    Viramontes KM; Neubert EN; DeRogatis JM; Tinoco R
    Front Immunol; 2022; 13():869768. PubMed ID: 35774790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection.
    Im SJ; Konieczny BT; Hudson WH; Masopust D; Ahmed R
    Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4292-4299. PubMed ID: 32034098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Lymphocytic Choriomeningitis Virus Strain Sustains Abundant Exhausted Progenitor CD8 T Cells without Systemic Viremia.
    Beura LK; Scott MC; Pierson MJ; Joag V; Wijeyesinghe S; Semler MR; Quarnstrom CF; Busman-Sahay K; Estes JD; Hamilton SE; Vezys V; O'Connor DH; Masopust D
    J Immunol; 2022 Nov; 209(9):1691-1702. PubMed ID: 36122933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsets of exhausted CD8
    Miller BC; Sen DR; Al Abosy R; Bi K; Virkud YV; LaFleur MW; Yates KB; Lako A; Felt K; Naik GS; Manos M; Gjini E; Kuchroo JR; Ishizuka JJ; Collier JL; Griffin GK; Maleri S; Comstock DE; Weiss SA; Brown FD; Panda A; Zimmer MD; Manguso RT; Hodi FS; Rodig SJ; Sharpe AH; Haining WN
    Nat Immunol; 2019 Mar; 20(3):326-336. PubMed ID: 30778252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion.
    Ahn E; Youngblood B; Lee J; Lee J; Sarkar S; Ahmed R
    J Virol; 2016 Oct; 90(19):8934-46. PubMed ID: 27466420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection.
    Gabriel SS; Tsui C; Chisanga D; Weber F; Llano-León M; Gubser PM; Bartholin L; Souza-Fonseca-Guimaraes F; Huntington ND; Shi W; Utzschneider DT; Kallies A
    Immunity; 2021 Aug; 54(8):1698-1714.e5. PubMed ID: 34233154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
    Richter K; Agnellini P; Oxenius A
    Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
    Jin HT; Anderson AC; Tan WG; West EE; Ha SJ; Araki K; Freeman GJ; Kuchroo VK; Ahmed R
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14733-8. PubMed ID: 20679213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor progenitor exhausted CD8
    Lan X; Mi T; Alli S; Guy C; Djekidel MN; Liu X; Boi S; Chowdhury P; He M; Zehn D; Feng Y; Youngblood B
    Nat Immunol; 2024 Jun; 25(6):1046-1058. PubMed ID: 38816618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYB orchestrates T cell exhaustion and response to checkpoint inhibition.
    Tsui C; Kretschmer L; Rapelius S; Gabriel SS; Chisanga D; Knöpper K; Utzschneider DT; Nüssing S; Liao Y; Mason T; Torres SV; Wilcox SA; Kanev K; Jarosch S; Leube J; Nutt SL; Zehn D; Parish IA; Kastenmüller W; Shi W; Buchholz VR; Kallies A
    Nature; 2022 Sep; 609(7926):354-360. PubMed ID: 35978192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling Virus-Specific Tcf1+ T Cell Repertoires During Acute and Chronic Viral Infection.
    Yermanos A; Sandu I; Pedrioli A; Borsa M; Wagen F; Oetiker N; Welten SPM; Pallmer K; Reddy ST; Oxenius A
    Front Immunol; 2020; 11():986. PubMed ID: 32547546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1
    Humblin E; Korpas I; Lu J; Filipescu D; van der Heide V; Goldstein S; Vaidya A; Soares-Schanoski A; Casati B; Selvan ME; Gümüş ZH; Wieland A; Corrado M; Cohen-Gould L; Bernstein E; Homann D; Chipuk J; Kamphorst AO
    Sci Immunol; 2023 Aug; 8(86):eadg0878. PubMed ID: 37624910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.
    Lee M; Im SK; Baek S; Ji M; Kim M; Lee EJ; Ji ST; Ferrando-Martinez S; Wolfarth A; Lee JY; Kim D; Choi D
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38471713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Intrinsic CD38 Expression Sustains Exhausted CD8
    DeRogatis JM; Neubert EN; Viramontes KM; Henriquez ML; Nicholas DA; Tinoco R
    J Virol; 2023 Apr; 97(4):e0022523. PubMed ID: 37039663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.